Payment overview · 2025
General Payments
$128.99
6 reported records · 6 companies
Healthcare provider profile · identity verified
Jeffrey K Leduff, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · JACKSON, MS · NPI 1912079161
Verified facts
What the public records show
CMS Open Payments records show Jeffrey K Leduff, M.D. received $128.99 in general payments during 2025 across 6 reported records.
SANOFI PASTEUR INC. accounted for 21.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 9 associated products.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 97 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 97 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Trulicity by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 138 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NURTEC ODT as an associated drug or biological on 217574 records involving 54025 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Nurtec Odt by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| SANOFI PASTEUR INC. | Unresolved — no canonical attribution shown | $27.99 | 21.7% | 1 | 2025 |
| Merck Sharp & Dohme LLC | Unresolved — no canonical attribution shown | $27.21 | 21.1% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $24.83 | 19.2% | 1 | 2025 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $16.94 | 13.1% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $16.05 | 12.4% | 1 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $15.97 | 12.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $128.99 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE Normalized: flublok quadrivalent northern hemisphere |
Biological | SANOFI PASTEUR INC. | $27.99 | 1 | 2025 |
Source payment records
|
|||||
| CAPVAXIVE Normalized: capvaxive |
Biological | Merck Sharp & Dohme LLC | $27.21 | 1 | 2025 |
Source payment records
|
|||||
| ABRYSVO Normalized: abrysvo |
Biological | PFIZER INC. | $24.83 | 1 | 2025 |
Source payment records
|
|||||
| COMIRNATY Normalized: comirnaty |
Biological | PFIZER INC. | $24.83 | 1 | 2025 |
Source payment records
|
|||||
| PREVNAR 20 Normalized: prevnar 20 |
Biological | PFIZER INC. | $24.83 | 1 | 2025 |
Source payment records
|
|||||
| OFEV Normalized: ofev |
Drug | Boehringer Ingelheim Pharmaceuticals, Inc. | $16.94 | 1 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $16.05 | 1 | 2025 |
Source payment records
|
|||||
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $15.97 | 1 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Lilly USA, LLC | $15.97 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
97 | 23 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
97 | 23 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
17 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
138 | 38 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | NURTEC ODT open payments reported associated product |
CMS Open Payments — General Payments 217574 supporting records · 54025 recipient NPIs · example record 1228794063 |
Nurtec Odt · 2024 Exact normalized brand match · 1 Part D row |
14 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 685 | 200 |
| Prednisone | Prednisone | 602 | 332 |
| Amlodipine Besylate | Amlodipine Besylate | 533 | 163 |
| Omeprazole | Omeprazole | 516 | 152 |
| Furosemide | Furosemide | 455 | 153 |
| Gabapentin | Gabapentin | 399 | 126 |
| Levothyroxine Sodium | Levothyroxine Sodium | 381 | 102 |
| Pantoprazole Sodium | Pantoprazole Sodium | 330 | 101 |
| Losartan Potassium | Losartan Potassium | 327 | 104 |
| Metformin Hcl | Metformin Hcl | 294 | 88 |
| Metoprolol Succinate | Metoprolol Succinate | 293 | 89 |
| Hydrochlorothiazide | Hydrochlorothiazide | 264 | 81 |
| Lisinopril | Lisinopril | 261 | 80 |
| Carvedilol | Carvedilol | 255 | 78 |
| Levofloxacin | Levofloxacin | 251 | 181 |
| Meloxicam | Meloxicam | 246 | 76 |
| Pravastatin Sodium | Pravastatin Sodium | 243 | 70 |
| Potassium Chloride | Potassium Chloride | 209 | 66 |
| Trazodone Hcl | Trazodone Hcl | 203 | 58 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 202 | 61 |
| Escitalopram Oxalate | Escitalopram Oxalate | 192 | 67 |
| Tamsulosin Hcl | Tamsulosin Hcl | 177 | 62 |
| Montelukast Sodium | Montelukast Sodium | 174 | 52 |
| Clopidogrel | Clopidogrel Bisulfate | 169 | 61 |
| Fluticasone Propionate | Fluticasone Propionate | 169 | 70 |
| Metoprolol Tartrate | Metoprolol Tartrate | 160 | 45 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 157 | 44 |
| Eliquis | Apixaban | 138 | 38 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 137 | 56 |
| Azithromycin | Azithromycin | 135 | 97 |
| Buspirone Hcl | Buspirone Hcl | 124 | 42 |
| Sertraline Hcl | Sertraline Hcl | 120 | 33 |
| Simvastatin | Simvastatin | 120 | 38 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 113 | 46 |
| Glimepiride | Glimepiride | 111 | 33 |
| Citalopram Hbr | Citalopram Hydrobromide | 109 | 28 |
| Allopurinol | Allopurinol | 108 | 34 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 105 | 29 |
| Spironolactone | Spironolactone | 100 | 36 |
| Duloxetine Hcl | Duloxetine Hcl | 99 | 20 |
| Hydralazine Hcl | Hydralazine Hcl | 98 | 34 |
| Jardiance | Empagliflozin | 97 | 23 |
| Quetiapine Fumarate | Quetiapine Fumarate | 92 | 19 |
| Atenolol | Atenolol | 91 | 25 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 88 | 23 |
| Naproxen | Naproxen | 85 | 28 |
| Pregabalin | Pregabalin | 82 | 16 |
| Amitriptyline Hcl | Amitriptyline Hcl | 81 | 19 |
| Famotidine | Famotidine | 80 | 27 |
| Bupropion Xl | Bupropion Hcl | 79 | 24 |
| Celecoxib | Celecoxib | 78 | 20 |
| Sucralfate | Sucralfate | 77 | 30 |
| Cefdinir | Cefdinir | 74 | 61 |
| Ropinirole Hcl | Ropinirole Hcl | 74 | 19 |
| Linzess | Linaclotide | 73 | 19 |
| Metformin Hcl Er | Metformin Hcl | 73 | 20 |
| Colchicine | Colchicine | 70 | 26 |
| Meclizine Hcl | Meclizine Hcl | 70 | 44 |
| Donepezil Hcl | Donepezil Hcl | 69 | 25 |
| Nifedipine Er | Nifedipine | 68 | 21 |
| Zolpidem Tartrate | Zolpidem Tartrate | 68 | 15 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 67 | 19 |
| Tizanidine Hcl | Tizanidine Hcl | 67 | 15 |
| Mirtazapine | Mirtazapine | 65 | 34 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 64 | 18 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 63 | 19 |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 61 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 57 | 19 |
| Fluconazole | Fluconazole | 57 | 41 |
| Symbicort | Budesonide/Formoterol Fumarate | 56 | 14 |
| Ozempic | Semaglutide | 52 | 11 |
| Ondansetron Odt | Ondansetron | 51 | 32 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 50 | 22 |
| Lovastatin | Lovastatin | 50 | 11 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 49 | 15 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 48 | 23 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 47 | 14 |
| Synthroid | Levothyroxine Sodium | 46 | 14 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 44 | 21 |
| Valacyclovir | Valacyclovir Hcl | 43 | 19 |
| Ezetimibe | Ezetimibe | 41 | 13 |
| Estradiol | Estradiol | 40 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 40 | 12 |
| Dicyclomine Hcl | Dicyclomine Hcl | 39 | 18 |
| Valsartan | Valsartan | 39 | 13 |
| Glipizide | Glipizide | 38 | 14 |
| Mupirocin | Mupirocin | 38 | 25 |
| Chlorthalidone | Chlorthalidone | 37 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 37 | 16 |
| Baclofen | Baclofen | 36 | suppressed |
| Fenofibrate | Fenofibrate | 36 | suppressed |
| Rybelsus | Semaglutide | 36 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 35 | suppressed |
| Methocarbamol | Methocarbamol | 35 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 34 | 13 |
| Propranolol Hcl | Propranolol Hcl | 33 | 11 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 32 | suppressed |
| Cephalexin | Cephalexin | 32 | 25 |
| Doxycycline Hyclate | Doxycycline Hyclate | 32 | 15 |
| Finasteride | Finasteride | 32 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 32 | suppressed |
| Hydrocortisone | Hydrocortisone | 32 | 12 |
| Memantine Hcl | Memantine Hcl | 32 | suppressed |
| Nitroglycerin | Nitroglycerin | 32 | 17 |
| Promethazine Hcl | Promethazine Hcl | 32 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 32 | 12 |
| Xarelto | Rivaroxaban | 32 | suppressed |
| Alprazolam | Alprazolam | 29 | suppressed |
| Olanzapine | Olanzapine | 29 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 28 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 27 | suppressed |
| Januvia | Sitagliptin Phosphate | 27 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 27 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 27 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 27 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 26 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 25 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 25 | suppressed |
| Nabumetone | Nabumetone | 24 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 24 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 23 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 23 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 23 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 22 | suppressed |
| Entresto | Sacubitril/Valsartan | 22 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 22 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 22 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 21 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 21 | suppressed |
| Brilinta | Ticagrelor | 20 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 20 | suppressed |
| Lansoprazole | Lansoprazole | 20 | suppressed |
| Metolazone | Metolazone | 20 | suppressed |
| Telmisartan | Telmisartan | 20 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 19 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 19 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 19 | suppressed |
| Klor-Con M20 | Potassium Chloride | 19 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 19 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 19 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 19 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 19 | 17 |
| Clonazepam | Clonazepam | 18 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 18 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 18 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 18 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 18 | suppressed |
| Novolin N | Insulin Nph Human Isophane | 18 | suppressed |
| Novolog Flexpen | Insulin Aspart | 18 | suppressed |
| Nystatin | Nystatin | 18 | 11 |
| Temazepam | Temazepam | 18 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 18 | suppressed |
| Aripiprazole | Aripiprazole | 17 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 17 | suppressed |
| Cilostazol | Cilostazol | 17 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 17 | suppressed |
| Lidocaine | Lidocaine | 17 | suppressed |
| Myrbetriq | Mirabegron | 17 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Trulicity | Dulaglutide | 17 | suppressed |
| Verapamil Er | Verapamil Hcl | 17 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 16 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 16 | suppressed |
| Levemir Flexpen | Insulin Detemir | 16 | suppressed |
| Levetiracetam | Levetiracetam | 16 | suppressed |
| Anastrozole | Anastrozole | 15 | suppressed |
| Eszopiclone | Eszopiclone | 15 | suppressed |
| Febuxostat | Febuxostat | 15 | suppressed |
| Ibuprofen | Ibuprofen | 15 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 15 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 15 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 14 | suppressed |
| Lactulose | Lactulose | 14 | suppressed |
| Metronidazole | Metronidazole | 14 | 12 |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 14 | suppressed |
| Nurtec Odt | Rimegepant Sulfate | 14 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 13 | suppressed |
| Repatha Sureclick | Evolocumab | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Topiramate | Topiramate | 13 | suppressed |
| Carbamazepine | Carbamazepine | 12 | suppressed |
| Clonidine | Clonidine | 12 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 12 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Latanoprost | Latanoprost | 12 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 12 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 11 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 11 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 11 | suppressed |
| Premarin | Estrogens, Conjugated | 11 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 11 | suppressed |
| Savella | Milnacipran Hcl | 11 | suppressed |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 11 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $128.99 · 6 records | SANOFI PASTEUR INC. | ABRYSVO, CAPVAXIVE, COMIRNATY, EVENITY, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, MOUNJARO, OFEV, PREVNAR 20, ZEPBOUND | 5 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Boehringer Ingelheim Pharmaceuticals, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error